administers grant
- A proteomics atlas of HIV/HBV co-infections for curing HBV
- A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)
- AGA EMPOWER-IBD: Clinical Effectiveness Factorial Randomization Trial
- Activity Probes to Guide Precision Microbiome Therapy
- Biopharma Agreement
- Breaching the species barrier: Towards an immunocompetent HBV-susceptible mouse model
- CAP-IT Center for LNP RNA Immunoprevention
- CTLA-4 regulation of intestinal health and inflammation
- Core B: Human Hepatocyte and Discovery
- Defining a novel regulator of innate lymphoid cells and intestinal health
- Defining host-microbe interactions in cancer and immunotherapy
- Defining novel mechanisms of microbiota in regulating anti-tumor responses
- EA Pharma Research Collaboration Agreement
- Emerging Therapeutic Paradigms in Inflammatory Bowel Disease
- Enhancing Immune Regulation In Gene Therapy For Hemophilia
- Fiber-induced Metabolites Promote UC Healing
- GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management
- Harnessing fecal RNA to better understand IBD and associated therapeutic response
- Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
- Immune analysis of the HBsAg seroclearance response terminating chronic HBV
- Immune regulation of intestinal health and disease
- Impact of HIV/HBV co-infections on circadian rhythm
- Innate immune regulation of host-microbe interactions
- Innate immune regulation of neuroinflammation
- Innate lymphoid cell regulation of the host-microbiota interactions in cancer
- Innate-like lymphocyte regulation of host-microbiota interactions in cancer
- Interleukin-2 regulation of mucosal inflammation
- Interrogation of a Novel Immuno-Regulatory Pathway in Colitis-Associated Cancer
- Investigating molecular mechanisms behind gut bacterial transamination and IBD
- Leveraging the Gut Microbiome to Regulate Hepatic Gluconeogenesis
- Long Title: System-Level Capture of Family History Data to Assess Risk of Cancer and provide Longitudinal Care Coordination
- Mechanisms of epithelial-mesenchymal crosstalk in intrahepatic biliary formation
- Microbiota, Metabolites, and Colon Neoplasia
- Modeling alcohol toxicity in human hepatocytes
- Molecular and clinical characterization of IBD patients naive or refractory to standard of care over time
- Multidisciplinary Research Training in Gastroenterology and Hepatology
- Multidisciplinary Research Training in Gastroenterology and Hepatology
- Nonalcoholic fatty liver disease, associated lipidomic changes, and preeclampsia risk
- Novel mechanisms protecting the gut from TNF
- Novel mechanisms protecting the gut from TNF
- Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte
- PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers
- Pregnancy in Inflammatory Bowel Disease And Neonatal Outcomes (PIANO)
- Project 3: Mechanisms of Innate and Adaptive Immune Responses to AAV-FVIII Gene Transfer
- Regulation of Enteric Nervous System Function by Group 3 Innate Lymphoid Cells
- Role for TL1A in innate intestinal inflammation and colitis associated cancer
- Standardized Microbiota Transplant Therapy in Crohn''s Disease, Pilot Trial
- TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
- Them1 Inhibitors for the Management of Non-Alcoholic Fatty Liver Disease
- Thioesterase-mediated lipotoxicity in liver and thermogenic adipose tissue
- Virus-host interactions for a cure against HBV